Mikhail Ryzhikov is a Postdoctoral Fellow in the Division of Pulmonary and Critical Care Medicine, Washington University in St. Louis, School of Medicine. He completed an undergraduate in Biochemistry and Biotechnology at University of Missouri, St. Louis and a Ph.D. in Biochemistry and Molecular Biology at Saint Louis University, School of Medicine.
Dr. Ryzhikov's doctoral training focused on bacterial and human DNA repair proteins and recombination mediator proteins, which are implicated in bacterial pathogenesis, cancer, aging, and are important for genome stability. This research encompassed protein purification, structural biology, biochemical, and biophysical protein characterization.
Postdoctoral work includes collaboration with industry to isolate Hepatitis B proteins to develop a new generation of drugs. In addition, Dr. Ryzhikov moved into transnational research by studying circadian rhythm genes implicated in asthma and other inflammatory disorders utilizing cellular and animal models as an NIH Fellow at Washington University in St. Louis.
